Glucagon Kit
Product Images NDC 85766-241

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Glucagon (NDC 85766-241). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sportpharm Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1a (Glucagon Figure1a)

A line graph depicting glucagon concentrations (ng/mL) over time (hours) following dosing. The x-axis represents time from dosing in hours (0 to 4), and the y-axis shows glucagon concentration with a peak occurring shortly after dosing, followed by a gradual decline. Error bars indicate variability at each time point.*

FDA Label Image

Figure 1b (Glucagon Figure1b)

A line graph depicting blood glucose concentrations (mg/dL) over time (hours). The y-axis shows blood glucose levels ranging from 0 to 160 mg/dL, while the x-axis shows time from 0 to 4 hours. Data points with error bars indicate glucose levels rising quickly, peaking just above 120 mg/dL before gradually declining and stabilizing around 80 mg/dL after 2 hours.*

FDA Label Image

Instructions 1 (Glucagon Instructions1)

Illustration showing a hand holding a small vial cap with an arrow indicating the direction to pull or remove the cap, likely part of instructions for opening or preparing the product.*

FDA Label Image

Instructions 2 (Glucagon Instructions2)

An instructional illustration showing a hand holding a syringe and a vial, with an arrow indicating the syringe needle being inserted into the vial, likely for drawing up a liquid medication. This image relates to the preparation or administration of the drug product Glucagon kit by Sportpharm LLC.*

FDA Label Image

Instructions 3 (Glucagon Instructions3)

An instructional diagram showing a hand turning a small rectangular object with a circular arrow indicating a twisting motion. This type of illustration is typically used to demonstrate how to open or activate a component of a medication kit, such as assembling or preparing the product for use.*

FDA Label Image

Instructions 4 (Glucagon Instructions4)

An instructional illustration showing a hand preparing a syringe by drawing liquid from a vial. A downward-pointing arrow indicates the direction of syringe plunger movement for drawing the liquid.*

FDA Label Image

Sequence (Glucagon Sequence)

Chemical structure diagram depicting the amino acid sequence of glucagon, a peptide hormone. The diagram shows the linear arrangement of individual amino acids from the N-terminal (H2N) to the C-terminal (COOH).*

FDA Label Image

1 (Label)

Label for Glucagon Emergency Kit for Low Blood Sugar by Sportpharm, NDC 85766-241-01. Packaging shows it contains one kit, manufactured by Amphastar Pharmaceuticals, Inc., with storage instructions and legal cautions. Includes a QR code and barcodes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.